Mysterious Virus Nipah: A Comprehensive Review

Authors

  • Bidduth Kumar Sarkar Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, Bangladesh
  • Alam Khan Department of Pharmacy, Comilla University, Kotbari, Cumilla, Bangladesh
  • Bithe Saha Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, Bangladesh
  • Susmoy Sarker Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, Bangladesh
  • Farjana Akter Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, Bangladesh
  • Barno Kumar Sarkar Faridpur Medical College, Faridpur, Bangladesh
  • Tanvir Ahmed Department of Pharmacy, Comilla University, Kotbari, Cumilla, Bangladesh
  • Sukalyan Kumar Kundu Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, Bangladesh

DOI:

https://doi.org/10.55489/njcm.160320254827

Keywords:

Nipah, Epidemics, Nosocomial, Zoonotic, CRISPR-based techniques, Pandemic

Abstract

Nipah virus is regarded as one of the most notorious and infectious viruses in the world with high mortality. This narrative literature review aims to offer basic information on the epidemiology, transmission methods, pathophysiology, treatment plan, diagnostic techniques, prevention about Nipah Virus those have been published using the digital repositories such as PubMed and Google Scholar. Results of reviewing relevant articles demonstrated that six hundred fifty (around 700) confirmed human cases of infections due to this virus were reported up until 2023. Between January 4 and February 13, 2023, seven districts in two divisions of Bangladesh (where outbreaks happen almost annually) experienced 73% case fatality rate and in 2024, again Bangladesh faced 100% mortality rate which is alarming issue in concern. The first infection case was recorded in Malaysia in 1998 with a mortality rate of close to 40%. Further outbreaks of the disease have occurred in different countries, particularly in South and Southeast Asia, over two decades later with a mortality rate above 50%. Specially in India, mortality rate reaches to its peak (100%) in two distinct areas in 2007 and 2021. Researchers from around the world are focusing on creating an effective vaccine, advanced diagnostic methods such as CRISPR-based techniques and active therapeutics due to its high pathogenicity in people and the absence of any treatment methods to combat it. Throughout history, viral outbreaks of different frequency and severity have wreaked misery all across the world and the Covid-19 worldwide pandemic provided an example of this type of scenario.

References

Skowron K, Bauza-Kaszewska J, Grudlewska-Buda K, et al. Nipah virus-Another threat from the world of zoonotic viruses. Frontiers in Microbiology. 2022; 12:811157. DOI: https://doi.org/10.3389/fmicb.2021.811157 PMid:35145498 PMCid:PMC8821941

Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philosophical Transactions of the Royal Society of London Series B. Biological Sciences. 2001;356(1411):983-9. DOI: https://doi.org/10.1098/rstb.2001.0888 PMid:11516376 PMCid:PMC1088493

Clayton B, Wang L, Marsh G. Henipaviruses: an updated review focusing on the pteropid reservoir and features of transmission. Zoonoses and public health. 2013;60(1):69-83. DOI: https://doi.org/10.1111/j.1863-2378.2012.01501.x PMid:22709528

Lo MK, Rota PA. The emergence of Nipah virus, a highly pathogenic paramyxovirus. Journal of Clinical Virology. 2008;43(4):396-400. DOI: https://doi.org/10.1016/j.jcv.2008.08.007 PMid:18835214

Singh RK, Dhama K, Chakraborty S, et al. Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies-a comprehensive review. Veterinary Quarterly. 2019;39(1):26-55. DOI: https://doi.org/10.1080/01652176.2019.1580827 PMid:31006350 PMCid:PMC6830995

Ramphul K, Mejias SG, Agumadu VC, et al. The killer virus called Nipah: a review. Cureus. 2018;10(8):e3168. DOI: https://doi.org/10.7759/cureus.3168

Harcourt BH, Tamin A, Ksiazek TG, et al. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology. 2000;271(2):334-49. DOI: https://doi.org/10.1006/viro.2000.0340 PMid:10860887

Wong K, Shieh W, Zaki S, et al. Nipah virus infection, an emerging paramyxoviral zoonosis. Springer seminars in immunopathology. 2002;24(2):215-28. DOI: https://doi.org/10.1007/s00281-002-0106-y PMid:12503066

Sun B, Jia L, Liang B, et al. Phylogeography, transmission, and viral proteins of Nipah virus. Virologica Sinica. 2018; 33:385-93. DOI:https://doi.org/10.1007/s12250-018-0050-1 PMid:30311101 PMCid:PMC6235768

Hauser N, Gushiken AC, Narayanan S, et al. Evolution of Nipah virus infection: past, present, and future considerations. Tropical medicine and infectious disease. 2021;6(1):24. DOI: https://doi.org/10.3390/tropicalmed6010024 PMid:33672796 PMCid:PMC8005932

Eaton BT, Broder CC, Middleton D, et al. Hendra and Nipah viruses: different and dangerous. Nature Reviews Microbiology. 2006;4(1):23-35. DOI: https://doi.org/10.1038/nrmicro1323 PMid:16357858 PMCid:PMC7097447

de Wit E, Prescott J, Falzarano D, et al. Foodborne transmission of nipah virus in Syrian hamsters. PLoS pathogens. 2014;10(3): e1004001. DOI: https://doi.org/10.1371/journal.ppat.1004001 PMid:24626480 PMCid:PMC3953481

Rana S, Singh S. Nipah Virus: Effects of Urbanization and Climate Change. In: Proceedings of the 3rd International Conference on Biological, Chemical & Environmental Sciences (BCES-2015); 2015 Sep 21-22; Kuala Lumpur, Malaysia.

Chua KB. Nipah virus outbreak in Malaysia. Journal of Clinical Virology. 2003;26(3):265-75. DOI: https://doi.org/10.1016/S1386-6532(02)00268-8 PMid:12637075

Chua KB, Goh KJ, Wong KT, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. The Lancet. 1999;354(9186):1257-9. DOI: https://doi.org/10.1016/S0140-6736(99)04299-3 PMid:10520635

Uppal P. Emergence of Nipah virus in Malaysia. Annals of the New York Academy of Sciences. 2000;916(1):354-7. DOI: https://doi.org/10.1111/j.1749-6632.2000.tb05312.x PMid:11193645

Kulkarni D, Tosh C, Venkatesh G, et al. Nipah virus infection: current scenario. Indian Journal of Virology. 2013;24(3):398-408. DOI: https://doi.org/10.1007/s13337-013-0171-y PMid:24426305 PMCid:PMC3832692

Sharma V, Kaushik S, Kumar R, et al. Emerging trends of Nipah virus: A review. Reviews in medical virology. 2019;29(1): e2010. DOI: https://doi.org/10.1002/rmv.2010 PMid:30251294 PMCid:PMC7169151

Hsu VP, Hossain MJ, Parashar UD, et al. Nipah virus encephalitis reemergence, Bangladesh. Emerging infectious diseases. 2004;10(12):2082. DOI: https://doi.org/10.3201/eid1012.040701 PMid:15663842 PMCid:PMC3323384

Epstein JH, Field HE, Luby S, et al. Nipah virus: impact, origins, and causes of emergence. Current infectious disease reports. 2006;8(1):59-65. DOI: https://doi.org/10.1007/s11908-006-0036-2 PMid:16448602 PMCid:PMC7088631

WHO's Health Emergencies Programme: acute emergencies monthly summary-February 2023-Programme. Weekly Epidemiological Record. 2023;98(13):139-44.

World Health Organization. Disease Outbreak News; Nipah virus infection - Bangladesh. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON508 Accessed 27th February, 2024.

Chadha MS, Comer JA, Lowe L, et al. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerging infectious diseases. 2006;12(2):235-240. DOI: https://doi.org/10.3201/eid1202.051247 PMid:16494748 PMCid:PMC3373078

Chatterjee P. Nipah virus outbreak in India. The Lancet. 2018;391(10136):2200. DOI: https://doi.org/10.1016/S0140-6736(18)31252-2 PMid:31876482

Verma A, Jain H, Sulaiman SA, et al. An impending public health threat: analysis of the recent Nipah virus outbreak and future recommendations-an editorial. Annals of Medicine and Surgery. 2024 Feb 1;86(2):638-42. DOI: https://doi.org/10.1097/MS9.0000000000001627 PMid:38333322 PMCid:PMC10849355

Cui Z, Li J, Meng L, et al. Nipah virus: A re-emerging public health concern. The Lancet Microbe. 2024 Mar 1;5(3): e212. DOI: https://doi.org/10.1016/S2666-5247(23)00361-0 PMid:38141635

World Health Organization. Disease Outbreak News; Nipah Virus Infection in India. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON490 Accessed 3th October, 2024.

As AK, Sahay RR, Radhakrishnan C, et al. Clinico‐epidemiological presentations and management of Nipah virus infection during the outbreak in Kozhikode district, Kerala state, India 2023. Journal of Medical Virology. 2024 Mar;96(3): e29559. DOI: https://doi.org/10.1002/jmv.29559 PMid:38529536

Ching PKG, de Los Reyes VC, Sucaldito MN, et al. Outbreak of henipavirus infection, Philippines, 2014. Emerging infectious diseases. 2015;21(2):328-331. DOI: https://doi.org/10.3201/eid2102.141433 PMid:25626011 PMCid:PMC4313660

Soman Pillai V, Krishna G, Valiya Veettil M. Nipah virus: past outbreaks and future containment. Viruses. 2020;12(4):465. DOI: https://doi.org/10.3390/v12040465 PMid:32325930 PMCid:PMC7232522

Baseler L, de Wit E, Scott DP, et al. Syrian hamsters (Mesocricetus auratus) oronasally inoculated with a Nipah virus isolate from Bangladesh or Malaysia develop similar respiratory tract lesions. Veterinary pathology. 2015;52(1):38-45. DOI: https://doi.org/10.1177/0300985814556189 PMid:25352203 PMCid:PMC6309986

Mire CE, Satterfield BA, Geisbert JB, et al. Pathogenic differences between Nipah virus Bangladesh and Malaysia strains in primates: implications for antibody therapy. Scientific reports. 2016;6(1):1-16. DOI: https://doi.org/10.1038/srep30916 PMid:27484128 PMCid:PMC4971471

DeBuysscher BL, de Wit E, Munster VJ, et al. Comparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamster. PLoS neglected tropical diseases. 2013;7(1): e2024. DOI: https://doi.org/10.1371/journal.pntd.0002024 PMid:23342177 PMCid:PMC3547834

Lam SK, Chua KB. Nipah virus encephalitis outbreak in Malaysia. Clinical Infectious Diseases. 2002;34(Supplement_2): S48-S51. DOI: https://doi.org/10.1086/338818 PMid:11938496

Han H-J, Wen H-l, Zhou C-M, et al. Bats as reservoirs of severe emerging infectious diseases. Virus research. 2015; 205:1-6. DOI: https://doi.org/10.1016/j.virusres.2015.05.006 PMid:25997928 PMCid:PMC7132474

Ang BS, Lim TC, Wang L. Nipah virus infection. Journal of clinical microbiology. 2018;56(6): e01875-17. DOI: https://doi.org/10.1128/JCM.01875-17 PMid:29643201 PMCid:PMC5971524

Jose BP. Nipah: The deadly menace. J Acad Clin Microbiol 2018;20:66-73. DOI: https://doi.org/10.4103/jacm.jacm_34_18

McLean RK, Graham SP. Vaccine development for Nipah virus infection in pigs. frontiers in Veterinary Science. 2019; 6:16. DOI: https://doi.org/10.3389/fvets.2019.00016 PMid:30778392 PMCid:PMC6369168

Nikolay B, Salje H, Khan AD, et al. A framework to monitor changes in transmission and epidemiology of emerging pathogens: lessons from Nipah virus. The Journal of Infectious Diseases. 2020;221(Supplement_4): S363-S9. DOI: https://doi.org/10.1093/infdis/jiaa074 PMid:32392322 PMCid:PMC7213557

Sazzad HM, Hossain MJ, Gurley ES, et al. Nipah virus infection outbreak with nosocomial and corpse-to-human transmission, Bangladesh. Emerging infectious diseases. 2013;19(2):210-217. DOI: https://doi.org/10.3201/eid1902.120971 PMid:23347678 PMCid:PMC3559054

Mondal MSH. The implications of population growth and climate change on sustainable development in Bangladesh. Jàmbá: Journal of Disaster Risk Studies. 2019;11(1):1-10. DOI: https://doi.org/10.4102/jamba.v11i1.535 PMid:30863507 PMCid:PMC6407464

Goh KJ, Tan CT, Chew NK, et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. New England Journal of Medicine. 2000;342(17):1229-35. DOI: https://doi.org/10.1056/NEJM200004273421701 PMid:10781618

Thomas B, Chandran P, Lilabi M, et al. Nipah virus infection in Kozhikode, Kerala, South India, in 2018: epidemiology of an outbreak of an emerging disease. Indian journal of community medicine: official publication of Indian Association of Preventive & Social Medicine. 2019;44(4):383-387. DOI: https://doi.org/10.4103/ijcm.IJCM_198_19 PMid:31802805 PMCid:PMC6881878

Uwishema O, Wellington J, Berjaoui C, et al. A short communication of Nipah virus outbreak in India: An urgent rising concern. Annals of Medicine and Surgery. 2022; 82:104599. DOI: https://doi.org/10.1016/j.amsu.2022.104599 PMid:36268453 PMCid:PMC9577510

Chattu VK, Kumar R, Kumary S, et al. Nipah virus epidemic in southern India and emphasizing "One Health" approach to ensure global health security. Journal of family medicine and primary care. 2018;7(2):275-283. DOI: https://doi.org/10.4103/jfmpc.jfmpc_137_18 PMid:30090764 PMCid:PMC6060941

Chua KB. Risk factors, prevention and communication strategy during Nipah virus outbreak in Malaysia. The Malaysian journal of pathology. 2010;32(2):75-80.

Giangaspero M. Nipah virus. Trop Med Surg. 2013;1:129. DOI: https://doi.org/10.4172/2329-9088.1000129

Tan C-T, Chua K-B. Nipah virus encephalitis. Current infectious disease reports. 2008;10(4):315-20. DOI: https://doi.org/10.1007/s11908-008-0051-6 PMid:18765105

Ochani RK, Batra S, Shaikh A, et al. Nipah virus-the rising epidemic: a review. Infez Med. 2019;27(2):117-27.

Halpin K, Rota P. A review of Hendra virus and Nipah virus infections in man and other animals. Zoonoses-Infections Affecting Humans and Animals: Focus on Public Health Aspects. 2015:997-1012. DOI: https://doi.org/10.1007/978-94-017-9457-2_40 PMCid:PMC7120151

Shaw ML. Henipaviruses employ a multifaceted approach to evade the antiviral interferon response. Viruses. 2009;1(3):1190-203. DOI: https://doi.org/10.3390/v1031190 PMid:21994589 PMCid:PMC3185527

Basler CF. Nipah and Hendra virus interactions with the innate immune system. Henipavirus: Ecology, Molecular Virology, and Pathogenesis. 2012:123-52. DOI: https://doi.org/10.1007/82_2012_209 PMid:22491899

Prescott J, de Wit E, Feldmann H, et al. The immune response to Nipah virus infection. Archives of virology. 2012; 157:1635-41. DOI: https://doi.org/10.1007/s00705-012-1352-5 PMid:22669317 PMCid:PMC3432143

Chua K, Lam S, Goh K, et al. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. Journal of Infection. 2001;42(1):40-3. DOI: https://doi.org/10.1053/jinf.2000.0782 PMid:11243752

Shariff M. Nipah virus infection: A review. Epidemiology & Infection. 2019;147:e95. DOI: https://doi.org/10.1017/S0950268819000086 PMid:30869046 PMCid:PMC6518547

Liebl DJ, Morris CJ, Henkemeyer M, et al. mRNA expression of ephrins and Eph receptor tyrosine kinases in the neonatal and adult mouse central nervous system. Journal of neuroscience research. 2003;71(1):7-22. DOI: https://doi.org/10.1002/jnr.10457 PMid:12478610

Weingartl H, Czub S, Copps J, et al. Invasion of the central nervous system in a porcine host by Nipah virus. Journal of virology. 2005;79(12):7528-34. DOI: https://doi.org/10.1128/JVI.79.12.7528-7534.2005 PMid:15919907 PMCid:PMC1143674

Mehnaz S, Anjum R, Mithila FR, et al. The Current Pathogenicity and Potential Risk Assessment of Nipah Virus as Potential Cause of "Disease X": A Narrative Review. Health Science Reports. 2024 Dec;7(12): e70241. DOI: https://doi.org/10.1002/hsr2.70241 PMid:39633830 PMCid:PMC11615694

Wiley CA. Emergent viral infections of the CNS. Journal of Neuropathology & Experimental Neurology. 2020 Aug 1;79(8):823-42. DOI: https://doi.org/10.1093/jnen/nlaa054 PMid:32647884

Escaffre O, Borisevich V, Rockx B. Pathogenesis of Hendra and Nipah virus infection in humans. Journal of infection in developing countries. 2013;7(4):308-11. DOI: https://doi.org/10.3855/jidc.3648 PMid:23592639

Rockx B, Brining D, Kramer J, et al. Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection. Journal of virology. 2011;85(15):7658-71. DOI: https://doi.org/10.1128/JVI.00473-11 PMid:21593160 PMCid:PMC3147900

Munster VJ, Prescott JB, Bushmaker T, et al. Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route. Scientific reports. 2012;2(1):1-8. DOI: https://doi.org/10.1038/srep00736 PMid:23071900 PMCid:PMC3471094

Hakanpaa L, Sipila T, Leppanen VM, et al. Endothelial destabilization by angiopoietin-2 via integrin β1 activation. Nature communications. 2015 Jan 30;6(1):5962. DOI: https://doi.org/10.1038/ncomms6962 PMid:25635707 PMCid:PMC4316742

Kawamura K, Takahashi T, Kanazawa M, et al. Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats. PLoS One. 2014 Jun 4;9(6): e98639. DOI: https://doi.org/10.1371/journal.pone.0098639 PMid:24896569 PMCid:PMC4045756

Kim ID, Cave JW, Cho S. Aflibercept, a VEGF (vascular endothelial growth factor)-trap, reduces vascular permeability and stroke-induced brain swelling in obese mice. Stroke. 2021 Aug;52(8):2637-48. DOI: https://doi.org/10.1161/STROKEAHA.121.034362 PMid:34192895 PMCid:PMC8312568

Genovese T, Impellizzeri D, D'Amico R, et al. Role of bevacizumab on vascular endothelial growth factor in apolipoprotein E deficient mice after traumatic brain injury. International Journal of Molecular Sciences. 2022 Apr 9;23(8):4162. DOI: https://doi.org/10.3390/ijms23084162 PMid:35456980 PMCid:PMC9024601

Wang L-F, Daniels P. Diagnosis of henipavirus infection: current capabilities and future directions. Henipavirus: Ecology, Molecular Virology, and Pathogenesis. 2012:179-96. DOI: https://doi.org/10.1007/82_2012_215 PMid:22481141

Tanimura N, Imada T, Kashiwazaki Y, et al. Monoclonal antibody-based immunohistochemical diagnosis of Malaysian Nipah virus infection in pigs. Journal of comparative pathology. 2004;131(2-3):199-206. DOI: https://doi.org/10.1016/j.jcpa.2004.03.006 PMid:15276859

Garbuglia AR, Lapa D, Pauciullo S, et al. Nipah virus: an overview of the current status of diagnostics and their role in preparedness in endemic countries. Viruses. 2023 Oct 7;15(10):2062. DOI: https://doi.org/10.3390/v15102062 PMid:37896839 PMCid:PMC10612039

Mazzola LT, Kelly-Cirino C. Diagnostics for Nipah virus: a zoonotic pathogen endemic to Southeast Asia. BMJ global health. 2019;4(Suppl 2): e001118. DOI: https://doi.org/10.1136/bmjgh-2018-001118 PMid:30815286 PMCid:PMC6361328

Guillaume V, Lefeuvre A, Faure C, et al. Specific detection of Nipah virus using real-time RT-PCR (TaqMan). Journal of virological methods. 2004;120(2):229-37. DOI: https://doi.org/10.1016/j.jviromet.2004.05.018 PMid:15288966

Pollak NM, Olsson M, Marsh GA, et al. Evaluation of three rapid low-resource molecular tests for Nipah virus. Frontiers in microbiology. 2023 Feb 9; 13:1101914. DOI: https://doi.org/10.3389/fmicb.2022.1101914 PMid:36845977 PMCid:PMC9949527

Daniels P, Ksiazek T, Eaton BT. Laboratory diagnosis of Nipah and Hendra virus infections. Microbes and infection. 2001;3(4):289-95. DOI: https://doi.org/10.1016/S1286-4579(01)01382-X PMid:11334746

Jin K, Huang P, Li B, et al. A Single‐Copy Sensitive and Field‐Deployable One‐Pot RT‐RPA CRISPR/Cas12a Assay for the Specific Visual Detection of the Nipah Virus. Transboundary and Emerging Diseases. 2024;2024(1):4118007. DOI: https://doi.org/10.1155/2024/4118007

Chong HT, Kamarulzaman A, Tan CT, et al. Treatment of acute Nipah encephalitis with ribavirin. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2001;49(6):810-3. DOI: https://doi.org/10.1002/ana.1062 PMid:11409437

Dawes BE, Kalveram B, Ikegami T, et al. Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Scientific reports. 2018;8(1):1-11. DOI: https://doi.org/10.1038/s41598-018-25780-3 PMid:29765101 PMCid:PMC5954062

Lo MK, Spengler JR, Krumpe LR, et al. Griffithsin inhibits Nipah virus entry and fusion and can protect Syrian golden hamsters from lethal Nipah virus challenge. The Journal of infectious diseases. 2020;221(Supplement_4): S480-S92. DOI: https://doi.org/10.1093/infdis/jiz630 PMid:32037447 PMCid:PMC7199786

Sissoko D, Laouenan C, Folkesson E, et al. Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS medicine. 2016 Mar 1;13(3): e1001967. DOI: https://doi.org/10.1371/journal.pmed.1002066 PMid:27284977 PMCid:PMC4902188

Shinkai M, Tsushima K, Tanaka S, et al. Efficacy and safety of favipiravir in moderate COVID-19 pneumonia patients without oxygen therapy: a randomized, phase III clinical trial. Infectious diseases and therapy. 2021 Dec;10(4):2489-509. DOI: https://doi.org/10.1007/s40121-021-00517-4 PMid:34453234 PMCid:PMC8396144

Hassan MZ, Rojek A, Olliaro P, et al. Improving clinical care of patients in Nipah outbreaks: moving beyond 'compassionate use'. The Lancet Regional Health-Southeast Asia. 2025 Jan 3;33:100527. DOI: https://doi.org/10.1016/j.lansea.2024.100527 PMid:39866590 PMCid:PMC11755010

Amaya M, Broder CC. Vaccines to emerging viruses: Nipah and Hendra. Annual review of virology. 2020; 7:447-73. DOI: https://doi.org/10.1146/annurev-virology-021920-113833 PMid:32991264 PMCid:PMC8782152

Soltan MA, Eldeen MA, Elbassiouny N, et al. Proteome based approach defines candidates for designing a multitope vaccine against the Nipah virus. International Journal of Molecular Sciences. 2021;22(17):9330. DOI: https://doi.org/10.3390/ijms22179330 PMid:34502239 PMCid:PMC8431361

Majee P, Jain N, Kumar A. Designing of a multi-epitope vaccine candidate against Nipah virus by in silico approach: a putative prophylactic solution for the deadly virus. Journal of Biomolecular Structure and Dynamics. 2021;39(4):1461-80. DOI: https://doi.org/10.1080/07391102.2020.1734088 PMid:32093573

Srivastava S, Verma S, Kamthania M, et al. Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health. Plos one. 2023;18(3): e0282580. DOI: https://doi.org/10.1371/journal.pone.0282580 PMid:36920996 PMCid:PMC10016716

Loomis RJ, Stewart-Jones GB, Tsybovsky Y, et al. Structure-based design of Nipah virus vaccines: a generalizable approach to paramyxovirus immunogen development. Frontiers in Immunology. 2020; 11:842. DOI: https://doi.org/10.3389/fimmu.2020.00842 PMid:32595632 PMCid:PMC7300195

Rodrigue V, Gravagna K, Yao J, et al. Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials. Tropical Medicine & International Health. 2024 May;29(5):354-64. DOI: https://doi.org/10.1111/tmi.13979 PMid:38415314

Jeon J, Kim E. Exploring Future Pandemic Preparedness Through the Development of Preventive Vaccine Platforms and the Key Roles of International Organizations in a Global Health Crisis. Vaccines. 2025 Jan 10;13(1):56. DOI: https://doi.org/10.3390/vaccines13010056 PMid:39852835 PMCid:PMC11768803

Leyva-Grado VH, Promeneur D, Agans KN, et al. Establishing an immune correlate of protection for Nipah virus in nonhuman primates. npj Vaccines. 2024 Dec 19;9(1):244. DOI: https://doi.org/10.1038/s41541-024-01036-2 PMid:39702562 PMCid:PMC11659318

Mishra G, Prajapat V, Nayak D. Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics. Immunology. 2024 Feb;171(2):155-69. DOI: https://doi.org/10.1111/imm.13695 PMid:37712243

Geisbert TW, Mire CE, Geisbert JB, et al. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Science translational medicine. 2014;6(242):242ra82-ra82. DOI: https://doi.org/10.1126/scitranslmed.3008929

García-Murria MJ, Expósito-Domínguez N, Duart G, et al. A bimolecular multicellular complementation system for the detection of syncytium formation: A new methodology for the identification of Nipah virus entry inhibitors. Viruses. 2019 Mar 7;11(3):229. DOI: https://doi.org/10.3390/v11030229 PMid:30866435 PMCid:PMC6466393

Negrete OA, Wolf MC, Aguilar HC, et al. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS pathogens. 2006 Feb;2(2): e7. DOI: https://doi.org/10.1371/journal.ppat.0020007 PMid:16477309 PMCid:PMC1361355

As Winter Nears, many in Bangladesh Fear a Nipah Virus Re-emergence. Available at: https://earthjournalism.net/stories/as-winter-nears-many-in-bangladesh-fear-a-nipah-virus-re-emergence Accessed 4th February, 2025.

Salah Uddin Khan M, Hossain J, Gurley ES, et al. Use of infrared camera to understand bats' access to date palm sap: implications for preventing Nipah virus transmission. Ecohealth. 2010; 7:517-25. DOI: https://doi.org/10.1007/s10393-010-0366-2 PMid:21207105

Ghosh S, Malik YS. Drawing comparisons between SARS-CoV-2 and the animal coronaviruses. Microorganisms. 2020 Nov 23;8(11):1840. DOI: https://doi.org/10.3390/microorganisms8111840 PMid:33238451 PMCid:PMC7700164

Hughes JM, Wilson ME, Luby SP, et al. Transmission of human infection with Nipah virus. Clinical infectious diseases. 2009 Dec 1;49(11):1743-8. DOI: https://doi.org/10.1086/647951 PMid:19886791 PMCid:PMC2784122

Alotaibi KD, Alharbi HA, Yaish MW, et al. Date palm cultivation: A review of soil and environmental conditions and future challenges. Land Degradation & Development. 2023 May 30;34(9):2431-44. DOI: https://doi.org/10.1002/ldr.4619

Kavvadias V, Le Guyader E, El Mazlouzi M, et al. Using date palm residues to improve soil properties: the case of compost and biochar. Soil Systems. 2024 Jun 24;8(3):69. DOI: https://doi.org/10.3390/soilsystems8030069

Vasudevan SS, Subash A, Mehta F, et al. Global and regional mortality statistics of nipah virus from 1994 to 2023: a comprehensive systematic review and meta-analysis. Pathogens and Global Health. 2024 Aug 17;118(6):471-80. DOI: https://doi.org/10.1080/20477724.2024.2380131 PMid:39030703

Singh M, Goldin K, Flagg M, Williamson BN, et al. Intracranial inoculation rapidly induces Nipah virus encephalitis in Syrian hamsters. PLOS Neglected Tropical Diseases. 2024 Oct 28;18(10): e0012635. DOI: https://doi.org/10.1371/journal.pntd.0012635 PMid:39466844 PMCid:PMC11542853

Kvam KA, Stahl JP, Chow FC, et al. Outcome and Sequelae of Infectious Encephalitis. Journal of Clinical Neurology (Seoul, Korea). 2024 Jan;20(1):23. DOI: https://doi.org/10.3988/jcn.2023.0240 PMid:38179629 PMCid:PMC10782093

Mire CE, Chan YP, Borisevich V, et al. A cross-reactive humanized monoclonal antibody targeting fusion glycoprotein function protects ferrets against lethal Nipah virus and Hendra virus infection. The Journal of infectious diseases. 2020 May 1;221(Supplement_4): S471-9. DOI: https://doi.org/10.1093/infdis/jiz515 PMid:31686101 PMCid:PMC7199785

Khan S, Akbar SM, Al Mahtab M, et al. Twenty-five years of Nipah outbreaks in Southeast Asia: A persistent threat to global health. IJID regions. 2024 Dec 1; 13:100434. DOI: https://doi.org/10.1016/j.ijregi.2024.100434 PMid:39308784 PMCid:PMC11414670

Mohapatra P, Khatib MN, Shabil M, et al. Addressing the Nipah virus threat: A call for global vigilance and coordinated action. Clinical Infection in Practice. 2024 Oct 12:100390. DOI: https://doi.org/10.1016/j.clinpr.2024.100390

Branda F, Ceccarelli G, Giovanetti M, et al. Nipah Virus: A Zoonotic Threat Re-Emerging in the Wake of Global Public Health Challenges. Microorganisms. 2025 Jan 9;13(1):124. DOI: https://doi.org/10.3390/microorganisms13010124 PMid:39858892 PMCid:PMC11767623

Downloads

Published

2025-03-01

How to Cite

1.
Sarkar BK, Khan A, Saha B, Sarker S, Akter F, Sarkar BK, Ahmed T, Kundu SK. Mysterious Virus Nipah: A Comprehensive Review. Natl J Community Med [Internet]. 2025 Mar. 1 [cited 2025 Mar. 23];16(03):326-41. Available from: https://njcmindia.com/index.php/file/article/view/4827

Issue

Section

Review Articles